Credit Suisse Ag Adagene Inc. Transaction History
Credit Suisse Ag
- $101 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding ADAG
# of Institutions
17Shares Held
10.9MCall Options Held
0Put Options Held
0-
Wu Xi App Tec Co., Ltd. Shanghai, F43.98MShares$11.2 Million37.94% of portfolio
-
Fil LTD Hamilton, D03.84MShares$10.8 Million0.01% of portfolio
-
Sc China Holding LTD N/A, K31.34MShares$3.79 Million0.4% of portfolio
-
Artal Group S.A. Luxembourg, N41.02MShares$2.88 Million0.15% of portfolio
-
General Atlantic LLC New York, NY264KShares$744,4800.02% of portfolio
About Adagene Inc.
- Ticker ADAG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,423,200
- Market Cap $122M
- Description
- Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...